NeoMed offers the complete enteral solution from breast to baby. NeoMed was the Innovator of the first comprehensive Enteral Safety System to comply
with recommendations set forth by the Joint Commission, FDA, ASPEN, and AAMI. NeoMed advocates the use of sterile products and aseptic technique to
deliver the healing breast milk that premature babies require. NeoMed enteral delivery products are designed to be incompatible with Luer or IV devices to
reduce the risk of misconnection errors. Reducing necrotizing enterocolitis (NEC) and gut disease, increasing the availability of human breast milk, and
increasing the shelf life of available HBM is the driving force behind NeoMed’s evolution of Enteral Nutrition Delivery Systems.
NeoMed is excited to announce their new international headquarters in Dublin, Ireland. NeoMed Innovative Medical Ventures, a subsidiary of NeoMed, is a newly formed Irish Corporation that will facilitate the launch of the NeoMed product line into the European marketplace.